June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Silicone Hydrogels as Drug Delivery Devices for Various Ocular Therapeutics
Author Affiliations & Notes
  • Frances Lasowski
    Chemical Engineering, McMaster University, Stoney Creek, ON, Canada
  • Heather Sheardown
    Chemical Engineering, McMaster University, Stoney Creek, ON, Canada
  • Footnotes
    Commercial Relationships Frances Lasowski, None; Heather Sheardown, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 6072. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Frances Lasowski, Heather Sheardown; Silicone Hydrogels as Drug Delivery Devices for Various Ocular Therapeutics. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):6072.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

Contact lenses are an attractive, minimally-invasive alternative to eye drops for various ocular therapeutics, such as roscovitine, atropine and timolol maleate for use in retinoblastoma, myopia and glaucoma conditions respectively. However, the uptake and release characteristics of these drugs vary greatly depending on the properties of the silicone hydrogel. Therefore, model lenses containing various drug loadings have been developed to determine the effect of material composition on subsequent drug release.

 
Methods
 

The model lenses contained various combinations of dimethylacrylamide (DMA), methacryloxypropyltris(trimethylsiloxy)silane (TRIS) and a hydroxyl-modified TRIS (modified TRIS). Drugs were loaded into the materials either directly during synthesis or by subsequent swelling in a drug solution. Release studies were performed into PBS solutions using UV- spectroscopy and HPLC to quantify release of each drug. Swelling, extraction, uptake and contact angle studies were also completed to characterize the materials.

 
Results
 

Most materials showed an appropriate water content (greater than 20%). The incorporation of the modified TRIS resulted in a quicker drug release for materials where the drug was directly loaded into the materials, though many showed sustained release greater than two weeks. As anticipated, materials containing both regular and modified TRIS (such as 80:10:10 DMA:TRIS:modified TRIS) showed drug release levels in between that of the single-silicone materials, though the release was more similar to the regular TRIS (such as 80:20 DMA:TRIS); this is seen in Figure 1 for one of the drugs studied. Similarly materials with greater DMA content tended to release the drugs faster than those with lower DMA contents. These results demonstrate that the drug release is highly correlated to the swelling of the material, though the amount of drug loading and method of loading is also important.

 
Conclusions
 

Alterations to the amount and method of drug loading, as well as the material compositions, alter the drug release kinetics. It is possible to sustain drug release for two weeks, the normal wear time of a contact lens, while maintaining appropriate contact lens material properties. This shows contact lenses are feasible for drug delivery to various ocular tissues.  

 
Figure 1. Roscovitine release from various material compositions loaded by soaking (material compositions given in mole percent).
 
Figure 1. Roscovitine release from various material compositions loaded by soaking (material compositions given in mole percent).

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×